MedTrace Logo

Effect of Ulinastatin on the Action of NDMRs (Rocuronium / Cisatracurium)

NCT05716256 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-07-08

No results posted yet for this study

Summary

The aim of this research was to determine the influence of ulinastatin on nondepolarising muscle relaxants Rocuronium and Cisatracurium.

Conditions

  • Nondepolarising Muscle Relaxants

Interventions

DRUG

Ulinastatin

The ulinastatin groups received ulinastatin 5000U/kg two minutes before the administration of muscle relaxants

DRUG

Placebo Comparator (0.9% NaCl)

The saline control groups received normal saline 0.1ml/kg two minutes before the administration of muscle relaxants

Sponsors & Collaborators

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Xu Hui · Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2023-06-15
Completion
2023-06-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05716256 on ClinicalTrials.gov